New York, NY (March 19, 2018)—In a recent study, researchers at Columbia University School of Nursing found that post-menopausal women, an expanding demographic among aging HIV patients, suffer more from fatigue and muscle aches than others living with HIV—findings that could support better care management for this growing patient population.
New University at Buffalo research that investigated the language preferences of Hispanic Americans seeking HIV testing in New York found that the majority of Hispanic patients preferred to receive care in Spanish, even if they were fluent in English.
A perspective in PLOS Medicine suggests that people with HIV who achieve viral suppression with antiretroviral therapy can avoid sexual transmission of HIV without using condoms, a significant study that lends hope that the “treatment as prevention” method can stop the spread of the HIV infection.
A new mouse study examines the fungus that causes cryptococcosis, which is a major source of illness in people with HIV and AIDS.
Johns Hopkins experts present at CROI 2018.
The National Institute for Drug Abuse has awarded NYU Meyers’ Center for Drug Use and HIV/HCV Research (CDUHR) a five-year, nearly $7.5 million grant to continue the center’s research.
A one-month antibiotic regimen to prevent active tuberculosis (TB) disease was at least as safe and effective as the standard nine-month therapy for people living with HIV, according to results of a large international clinical trial. Adults and adolescents in the trial were more likely to complete the short-course regimen consisting of daily doses of the antibiotics rifapentine and isoniazid for four weeks than the standard nine-month regimen of daily isoniazid.
Researchers at New York University College of Dentistry, in collaboration with Rheonix, Inc., are developing a novel test for Zika virus that uses saliva to identify diagnostic markers of the virus in a fraction of the time of current commercial tests.
A novel microarray patch for HIV PrEP is in preparation for future clinical trials. The consortium of Queen’s University Belfast, along with their collaborators, PATH, ViiV Healthcare, the Population Council and LTS Lohmann Therapie-Systeme AG have been granted over $10 million by USAID for their research.
Researchers at the University of Illinois at Chicago will conduct a study to determine how the use of menstrual cups helps prevent vaginal infections and sexually transmitted infections.“One of the most common vaginal infections, bacterial vaginosis, doubles the risk for acquiring or transmitting HIV,” said Supriya Mehta, associate professor of epidemiology in the UIC School of Public Health and principal investigator on the study.
Queen’s University Belfast is playing a central role in an international consortium that has announced the development of a patch delivery system which will lower the chances of infection for those at very high risk of HIV.
Significant breakthrough could hasten an eventual HIV cure as modified antiviral drug is able to reach cells and tissues where HIV resides
In an effort to combat new HIV infections among men who inject drugs in Vietnam, researchers at the University of North Carolina at Chapel Hill conducted the first study to explore how this population mixes together. Their results were published in the Journal of Acquired Immune Deficiency Syndromes.
Interpersonal psychotherapy is a common, in-person treatment for depression, but new research from the University of Georgia found that this type of one-on-one therapy can be successfully delivered over the telephone.
The University of Alabama at Birmingham's 1917 Clinic celebrates 30 years of treatment for those living with HIV. In it's first year, the clinic saw just 100 people but three decades later, the clinic has served more than 12,000 patients. The need for care has enabled the 1917 Clinic to be the largest HIV medical provider in the state, as well as a national leader in care.
A review of more than 80 studies reveals that changes in the immune cells of people with human immunodeficiency virus (HIV) infection may increase their risk of cardiovascular disease (CVD).
Billions of US taxpayer dollars have been invested in Africa over the past 15 years to improve care for millions suffering from the HIV/AIDS epidemic; yet health systems on the continent continue to struggle. What if the investments and lessons learned from HIV could be used to improve care for those with other serious chronic conditions? With this question in mind, researchers from Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center, along with investigators and clinicians based in Uganda, borrowed an HIV/AIDS innovation to seek inroads against rheumatic heart disease in sub-Saharan Africa.
Conducting HIV testing among the social and risk networks of those recently diagnosed with HIV helps identify undiagnosed cases of HIV at significantly higher rates and at a lower cost than other testing approaches, finds a new study conducted in Ukraine by an international research team.
A research team at GW School of Medicine and Health Sciences found that latent HIV reservoirs exhibit resistance to elimination by CD8+ T-cells of people living with the virus.
Recent studies testing multivalent combinations of three broadly neutralizing antibodies, or bnAbs, have yielded promising results in animal models of HIV prevention. Two investigators at the University of North Carolina at Chapel Hill describe the potential of bnAbs to inform HIV prevention, treatment and cure strategies in a recent article in the New Journal of Medicine.
A new study that seeks to ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches and, ultimately, more effective HIV treatment strategies.
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.
The Center for Drug Use and HIV/HCV Research (CDUHR) at NYU Rory Meyers College of Nursing has increasingly focused its research on opioid abuse, both in urban and rural settings.
Replacing the popular contraceptive shot known as DMPA with alternative methods of contraception could help protect women in sub-Saharan Africa and other high-risk regions from becoming infected with HIV.
Transitioning away from a popular contraceptive shot known as DMPA could help protect women in Sub-Saharan Africa and other high-risk regions from becoming infected with HIV, according to a research review published in the Endocrine Society’s journal Endocrine Reviews.
Through gene therapy, researchers engineered blood-forming stem cells (hematopoietic stem/progenitor cells, or HSPCs) to carry chimeric antigen receptor (CAR) genes to make cells that can detect and destroy HIV-infected cells. These engineered cells persisted for more than two years
The development of an HIV vaccine has proven extraordinarily difficult. One of the reasons is that naïve precursor B cells that can give rise to mature B cells producing broadly neutralizing antibodies are exceedingly rare within the average human. Yet, despite their low frequency these B cell precursors can outcompete their B cell competitors under the right conditions.
A class of anti-inflammatory drugs already FDA-approved for rheumatoid arthritis could “purge” the reservoir of infected immune cells in people infected by HIV, according to new research.
Researchers at the Duke Human Vaccine Institute have led an effort to develop a more accurate way to gauge the incidence of HIV infections in large populations, which will improve research and prevention strategies worldwide.
Moving the Office of Global AIDS Coordinator, which oversees and manages PEPFAR, out of the U.S. State Department would likely provide little benefit and could have a profoundly negative impact on its ability to effectively lead the global fight against HIV/AIDS, concludes a report with input from leading global health experts and former officials from both Republican and Democratic administrations.
Research from the Monell Center documented wide individual differences to the taste of the life-saving HIV medication Kaletra and identified genetic sources of the taste variation. The findings suggest that the growing field of pharmacogenetics should assess the sensory response to medicines to promote medication compliance and treatment success.
A chemical found in marijuana, known as tetrahydrocannabinol, or THC, has been found to potentially slow the process in which mental decline can occur in up to 50 percent of HIV patients, says a new Michigan State University study.
When HIV-1 infects an immune cell, the virus travels to the nucleus so quickly there's not enough time to set off the cell's alarm system. Loyola researchers have discovered the protein that helps the virus travel so fast. Without this protein, the virus became stranded in the cytoplasm, where it was detected by the viral defense system.
international partners are announcing the first efficacy study for an investigational HIV-1-preventive “mosaic” vaccine. Janssen Pharmaceutical Companies of Johnson & Johnson are joining forces with The Bill & Melinda Gates Foundation and National Institutes of Health on this study, and they have enlisted the aid of top researchers worldwide to conduct the trial.
In a study led by the University of Delaware and the University of Pittsburgh School of Medicine, researchers discovered a "brake" that interferes with HIV's development into an infectious agent. This mechanism prevents the capsid - the protein shell covering the virus - from forming.
To help empower women in low- and middle-income countries and improve their health, the U.S. Agency for International Development through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) awarded RTI International a $4.8 million cooperative agreement to develop a dual-purpose drug delivery device for both HIV and pregnancy prevention that can be successfully used in these settings.
A steep drop in the local incidence of new HIV infections accompanied the rollout of a U.S.-funded anti-HIV program in a large East-African population, according to a study led by researchers at Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine.
Experts from Johns Hopkins Medicine are available to talk about AIDS/HIV, and there is new research from Johns Hopkins on the topic.
Brand new NCCN Guidelines® map out best practices for treating patients with AIDS-related Kaposi sarcoma.
Media Pitch
Health officials are urging people at risk for HIV to take a daily pill that provides near-total protection against transmission
People with both HIV and risk factors for heart disease and stroke were less likely to be treated with cholesterol-lowering statin drugs and aspirin than patients without HIV.
Malaria parasites, although widespread among wild chimpanzees and gorillas, have not been detected in bonobos, a chimp cousin. Although the researchers saw evidence of a new malaria species in bonobos, it was limited to one small area of their range. This work helps the hunt for biological loopholes to potentially exploit the life history of ape pathogens to better understand how they cross over to humans.
Computer modeling has helped a team of scientists, including several scholars from the University of Chicago, to decode previously unknown details about the "budding" process by which HIV forces cells to spread the virus to other cells. The findings, published Nov. 7 in Proceedings of the National Academy of Sciences, may offer a new avenue for drugs to combat the virus.
Rural counties continue to rank lowest among counties across the U.S., in terms of health outcomes. A group of national organizations including the Robert Wood Johnson Foundation and the National 4-H Council are leading the way to close the rural health gap.
HIV patients and their doctors are urged to be more aware of the additional health risks associated with treated HIV infection. This follows new research that shows HIV patients at high risk for a heart attack or stroke are also at substantially greater risk for chronic kidney disease and vice versa.
The research team compared samples of vaginal microbiota of both women who were involved in sex work and those who were not sex workers in Nairobi, Kenya.
UCLA is co-sponsoring a major conference spotlighting the impact of HIV/AIDS on black women at the local, state and national levels. “A Paradigm Shift: The Impact of HIV/AIDS on African American Women and Families”, runs Nov. 2-3 at the Morehouse School of Medicine in Atlanta.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right